Cancer: Drug with new approach on impeding DNA repair shows promise in first clinical trial
Monday, June 15, 2020 - 18:30
in Health & Medicine
Berzosertib, an ATR-targeting drug, improves progression-free survival in combination with chemotherapy in patients with high-grade serous ovarian cancer.